Analyst
Nomura
Equibles does not estimate personal net worth.
Sain Mukherjee is recorded as Analyst at Nomura. Sain Mukherjee has spoken on 2 earnings calls across 2 companies, most recently for Gland Pharma Limited on November 6, 2026. Those appearances were for Gland Pharma Limited and IPCA Laboratories Limited. The companies whose calls Sain Mukherjee spoke on are classified in the Healthcare sector.
“In the first half, we have seen almost 21% revenue growth with good traction in U.S., Europe, but other markets, and as you mentioned, there was an issue.”
“Mr. Jay, I wanted to check on ZeroDoll franchise. What's the kind of growth you're seeing, and if you can split between volume and price increase in this, and what's the headroom to grow this franchise?”
Nomura
Analyst
Transcript header (unverified)
Gland Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
IPCA Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Gland Pharma Limited
Earnings Call
IPCA Laboratories Limited
